Trial intelligence / Profile preview

Sunitinib in Neoadjuvant Breast Cancer

NCT00656669Phase 2Completed

Sponsor
Indiana University
Start
Apr 2008
Primary completion
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sunitinib in breast cancer, sponsored by Indiana University. Started Apr 2008; status: completed.

02

Drugs

sunitinib
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00656669.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00656669.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call